COMPARISON OF PROPENSITY SCORES FOR SURGICAL TREATMENT OF BIOPROSTHETIC MITRAL VALVE DYSFUNCTION USING TRADITIONAL AND “VALVE-IN-VALVE” METHODS
-
Published:2023-06-25
Issue:2
Volume:12
Page:57-69
-
ISSN:2587-9537
-
Container-title:Complex Issues of Cardiovascular Diseases
-
language:
-
Short-container-title:Kompleks. probl. serdečno-sosud. zabol.
Author:
Khalivopulo Ivan K.1ORCID, Evtushenko Aleksey V.1ORCID, Shabaldin Andrey V.1ORCID, Troshkinev Nikita M.1ORCID, Stasev Alexander N.1ORCID, Kokorin Stanislav G.1ORCID, Barbarash Leonid S.1ORCID
Affiliation:
1. Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”
Abstract
HighlightsThe article describes the first conducted pseudorandomized comparative study of mitral valve replacement using either traditional or “valve-in-valve” techniques. AbstractAim. To compare short-term (perioperative) and medium-term (6 months) outcomes of surgical treatment of bioprosthetic mitral valve dysfunction using traditional and “valve-in-valve” methods.Methods. The study included 18 patients undergoing “valve-in-valve” replacement and 18 patients undergoing traditional mitral valve replacement (open mitral valve replacement) chosen according to the following criteria: heart disease type, predominant type of defect, age, gender, severity of the disease and the presence of concomitant pathology and using 1:1 matching on the propensity score.Results. No perioperative mortality was noted in both groups. The cardiopulmonary bypass and cross-clamping of the aorta time was significantly lower in the “valve-in-valve” group. Comparison of echocardiographic parameters revealed a decrease in the mean pulmonary arterial pressure gradient, and a decrease in the size of the heart chambers in both groups. The peak and mean transvalvular gradient were lower in the “traditional” group. There were no cases of patient-prosthesis mismatch. In the mid-term period, patients in both groups presented with a lower functional class of heart failure.Conclusion. Bioprosthetic mitral valve replacement using the “valve-in-valve” technique provides comparable clinical and hemodynamic results compared to the “traditional” technique in short-term and mid-term periods, and significantly reduces cardiopulmonary bypass and aortic cross clamping time.
Subject
Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Rehabilitation,Emergency Medicine,Surgery
Reference37 articles.
1. Chen J., Li W., Xiang M. Burden of valvular heart disease, 1990-2017: Results from the Global Burden of Disease Study 2017. J Glob Health. 2020;10(2):020404. doi: 10.7189/jogh.10.020404 2. Rabochaya gruppa po vedeniyu patsientov s klapannoi bolezn'yu serdtsa evropeiskogo obshchestva kardiologov (EOK, ESC) i evropeiskoi assotsiatsii kardio-torakal'noi khirurgii (EACTS) rekomendatsii ESC/EACTS 2017 po lecheniyu klapannoi bolezni serdtsa (tekst dostupen v elektronnoi versii). Rossiiskii kardiologicheskii zhurnal. 2018; (7): 103-155. doi. 10.15829/1560-4071-2018-7-103-155 3. Bokeriya L.A., Milievskaya E.B., Kudzoeva Z.F., Pryanishnikov V.V. Serdechno-sosudistaya khirurgiya–2017. Bolezni i vrozhdennye anomalii sistemy krovoobrashcheniya.M.: Izdatel'stvo NMTsSSKh im. A.N.Bakuleva MZ RF; 2018. 4. Kaneko T., Aranki S., Javed Q., McGurk S., Shekar P., Davidson M., Cohn L.. Mechanical versus bioprosthetic mitral valve replacement in patients <65 years old. J Thorac Cardiovasc Surg. 2014;147(1):117-26. doi: 10.1016/j.jtcvs.2013.08.028 5. Vahanian A., Beyersdorf F., Praz F., Milojevic M., Baldus S., Bauersachs J., Capodanno D., Conradi L., De Bonis M., De Paulis R., Delgado V., Freemantle N., Gilard M., Haugaa K.H., Jeppsson A., Jüni P., Pierard L., Prendergast B.D., Sádaba J.R., Tribouilloy C., Wojakowski W.; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561-632. doi: 10.1093/eurheartj/ehab395
|
|